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Ewing Sarcoma is the second most common primary malignant bone tumor in children and young adults
following osteosarcoma, but exceptionally it can arise from extraskeletal sites also. Extraskeletal Ewing
Sarcoma is of neuroectodermal origin and usually involves extremities, retroperitoneum and para-
vertebral regions. In literature, we have found only two case reports of Extraskeletal Ewing Sarcoma
involving abdominal wall in adults. We present a neonate who was born with a mass at left anterolateral
abdominal wall which turned out to be Ewing Sarcoma. To the best of our knowledge, this is the ﬁrst case
of Extraskeletal Ewing’s Sarcoma in a neonate involving abdominal wall.
 Open access under CC BY-NC-ND license.Ewing sarcoma is a bone neoplasm that usually occurs in chil-
dren and young adults but rarely it can arise from soft tissue,
labeled as Extraskeletal Ewing Sarcoma. We present a neonate who
was born with a mass at left anterolateral abdominal wall which
turned out to be Ewing Sarcoma and patient is now in 12th month
follow up at Paediatric Oncology Department.
1. Case report
A 7 days old, full termmale neonate, born through caesarian sec-
tion at a District hospital and was referred to us with complaint of
swelling left anterolateral abdomen since birth. There was no history
of fever, GIT or urinary complaints and respiratory distress. Patient
had birthweight of 2.5 kg and therewas nohistory of any drug intake
by mother during gestation. On examination patient was pale with
normal vital signs. Examination of swelling showed a round multi-
lobed swelling measuring 15  10 cm present on left anterolateral
aspect of abdomen with overlying veins and no obvious signs of
inﬂammation; however thereweremultiple areas of redness over the
swelling. Swellingwasnontenderwithnormaloverlying temperature
and not transilluminant. It was ﬁxed to the underlying tissues
extraperitoneal, irreducible and had adherent overlying skin. Hiscom, nayerbsh@gmail.com
Inc. Open access under CC BY-NC-NDlaboratory reports showed anemia (Hb: 7.2mg/dl). Ultrasound of the
swelling showed a mass in left ﬂank with high velocity blood ﬂow
with suspicion of lymph-hemangioma. His MRI showed that bulk of
the mass was within the subcutaneous tissue with stretching of the
overlying skin and no inﬁltration into the underlying and deep
structures of the abdomen noted. The mass was isointense on T1W1
with few hyperintense foci, mixed signal intensity onT2W1and STIR.
Our radiologist had a suspicion of Teratoma, so his AFP levels were
advised but that was also within normal range. His excision biopsy
was planned and patient was optimized after blood transfusion.
Peroperatively mass was extending to abdominal wall muscles only
with no intraperitoneal extension. Mass was excised completely and
muscles were repaired. Skin defect was closed by skin grafting. His
postoperative recovery remained uneventful. His biopsy report
showed it to be round blue cell tumor which was further labeled as
Ewing Sarcoma after immunohistochemicals staining (CD 99). His
metastatic workup including bone scan was obtained which turned
out to be normal. His CT chest showed few indeterminate subpleural
nodules measuring 2e3 cm in both lungs. Patient was referred to
Paediatric Oncology Department for further management. Patient
was lost in followup for 6months and thenhepresented to Paediatric
Oncologist for management. Oncologist decided to observe the
patient andnot to start chemotherapy. Patient is inour strict followup
and is now 1 year old; and is doing well to date.
2. Discussion
Extraskeletal Ewing Sarcoma (EES)/Primitive Neuroectodermal
Tumor (PNET) are rare lesions which are of soft tissue origin. They
usually originate from extremities, retroperitoneum, chest wall and license.
Fig. 1. Mass present on lateral abdominal wall.
Fig. 3. MRI of mass on lateral abdominal wall.
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bladder and rarely abdominal wall. They usually affect young ado-
lescents and adults between age of 10 and 30 years with slight male
predominance. Theymost commonly present as mass in soft tissues
but it varies and depends upon site of origin [1].
EES is of neuroectodermal origin and one of the round blue cell
tumors. Classically it is composed of small round cells, arranged in
sheets and blue in color. The cells have high N/C ratio and vacuo-
lated cytoplasm because of presence of glycogen; nuclei are round
with “salt & pepper” chromatin [2]. Further deﬁnitive distinction
into Ewing sarcoma/PNET requires usage of speciﬁc immunohis-
tochemical markers like CD99 (MIC-2). This family of tumors shares
common cytogenetic and molecular changes that involve trans-
location of the ES gene on chromosome 22 (22q12) onto several
other genes such as FLI-1 on chromosome 11 (11q24) in 90% of cases
and rearrangement on chromosome 21 (21q22). In addition, it ap-
pears that patients carrying the transcript EWS/FLI-1 have slower
tumor growth than other transcripts and better response to
chemotherapy [3]. Radiological diagnosis might require Ultrasound,
CT and MRI with nonspeciﬁc ﬁndings [4].
The treatment of EES involves both chemotherapy and radiation
therapy along with surgical resection. The consistent use of chemo-
therapy regimen in treatment of localized disease has signiﬁcantly
increased 5 and 10-year survival rates [5]. The prognosis of EES is
considered better than Ewing Sarcoma of bone [6]. Various drugs had
been used previously for treatment of Ewing Sarcoma; now trials of
EURO.E.W.I.N.G have been using 6 courses of Vincristine, Iso-
fosfamide,Doxurubicin, Etoposide (VIDE) as induction chemotherapy
[7]. Age at the timeof diagnosis is considered a good prognostic factor
as patients of age14 years were found to have overall survival rates
of 66% and 61% at 5 and 10 years compared to older patients with
corresponding survival rates of 47% and 31% [8].Fig. 2. Excised mass.Due to rarity of congenital Ewing sarcoma cases, there is no
deﬁnitive protocol for neonates deﬁned yet. According to Kim et al,
21 cases of congenital Ewing sarcoma had been reported till 2008.
The common feature among those of survivals in their series was
surgery followed by chemotherapy/radiotherapy [9]. Also because
of immaturity of organs in neonates, chemotherapy carries a lot of
hazardous effects ad it is really an issue to decide for adjuvant
therapy. Same was the dilemma in our case in which after local
control of disease, it was a real tough question whether to go for
chemotherapy or not. In our case, oncology board decided to wait
for follow up and not to start treatment because of the hazards of
chemotherapy and radiotherapy at this age (Figs. 1e3).
Two case reports of EES involving abdominal wall have been
found which were of patients of age of 35 and 65 years, but no case
of EES in neonates involving abdominal wall has yet been reported
[2,10].3. Conclusion
Congenital Extraskeletal Ewing sarcoma is although rare but an
important entity. Complete surgical excision with safe surgical
margins should be considered a primary treatment but decision for
chemotherapy varies from case to case.References
[1] Xie Chun-Fang, Liu Meng-Zhoung, Xi Mian. Extraskeletal Ewing Sarcoma:
a report of 15 cases and literature review. Chin J Cancer 2010;29:420e4.
[2] Aydinli B, Ozturk G, Yildirgan MI, Polat KY, Basoglu M, Gundogdu C, et al.
Extraskeletal Ewing’s sarcoma in the abdominal wall: a case report. Acta Oncol
2006;45:484e6.
[3] Turkyilmaz Z, Sonmez K, Karabulut R, Sen MC, Poyraz A, Oguz A, et al.
Extraskeletal Ewing sarcoma of the mesocolon in a child. J Pediatr Surg
2012:47.
[4] Bjerklund Johansen TE, Huseby A, Stenwig JT. Extraskeletal Ewing’s sarcoma
contiguous with the seminal vesicle. Scand J Urol Nephrol 1988;22:237e9.
[5] Reali A, Mortellaro G, Allis S, Trevisiol E, Anglesio SM, Bartoncini S, et al. A case
of primary mediastinal Ewing’s sarcoma/primitive neuroectodermal tumor
presenting with initial compression of superior vena cava. Ann Thorac Med
2013;8:121e3.
[6] Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC, et al.
Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.
Cancer 2011;117:3027e32.
[7] Ladenstein R, Pötschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O,
et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro-
EWING 99 trial. J Clin Oncol 2010;28:3284e91.
[8] Ullmann C, Beck JD, Holter W, Petsch S, Dunst J, Sauer R, et al. Long-term
results following multidisciplinary treatment of localized Ewing’s sarcoma in
children and adolescents. Strahlenther Onkol 2008;184:137e44.
[9] Kim SY, Tsokos M, Helman LJ. Dilemmas associated with congenital ewing
sarcoma family tumors. J Pediatr Hematol Oncol 2008;30:4e7.
[10] Askri A, Farhat LB, Ghariani B, Rabeh A, Dali N, Said W, Hendaoui L. Extra-
skeletal Ewing Sarcoma of the abdominal wall. Cancer Imag 2008;8:156e8.
